Imipenem/Cilastatin-XNW4107
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Imipenem/Cilastatin-XNW4107, covering 2023-02-16 to 2025-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2) [Phase 3]